T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Mohawk Industries
MHK
$9.42B
| $83M | 0.01% |
455,492
-15,425
| -3% | -$2.75M |
|
827
CRISPR Therapeutics
CRSP
$5.22B
| $82.7M | 0.01% |
1,090,813
-93,916
| -8% | -$8.2M |
|
828
Charles River Laboratories
CRL
$13.4B
| $82.7M | 0.01% |
219,371
-2,413
| -1% | -$937K |
|
829
United Airlines
UAL
$41B
| $81.9M | 0.01% |
1,871,100
-1,001,752
| -35% | -$46.5M |
|
|
HONE
830
DELISTED
HarborOne Bancorp
HONE
| $81.8M | 0.01% |
5,511,879
-27,973
| -0.5% | -$407K |
|
831
Texas Pacific Land
TPL
$23.9B
| $81.7M | 0.01% |
588,861
-166,050
| -22% | -$23.2M |
|
832
Maravai LifeSciences
MRVI
$861M
| $81.6M | 0.01% |
1,946,736
+418,203
| +27% | +$16.9M |
|
|
IAA
833
DELISTED
IAA, Inc. Common Stock
IAA
| $81.4M | 0.01% |
1,608,379
-151,181
| -9% | -$8.04M |
|
834
Realty Income
O
$59.6B
| $81.3M | 0.01% |
1,136,163
+363,365
| +47% | +$25M |
|
835
Preferred Bank
PFBC
$1.28B
| $81.3M | 0.01% |
1,132,176
-223
| -0% | -$15.4K |
|
836
Clearwater Paper
CLW
$354M
| $81.1M | 0.01% |
2,211,034
-11,757
| -0.5% | -$469K |
|
837
Petco
WOOF
$817M
| $81M | 0.01% |
4,094,659
-49,463
| -1% | -$1.08M |
|
838
Southern Copper
SCCO
$158B
| $80.2M | 0.01% |
1,419,378
-34,335
| -2% | -$1.89M |
|
839
Boston Omaha
BOC
$431M
| $79.9M | 0.01% |
2,781,630
-34,855
| -1% | -$1.14M |
|
840
Texas Capital Bancshares
TCBI
$4.38B
| $79.8M | 0.01% |
1,325,137
+209,275
| +19% | +$12.6M |
|
|
AESC
841
DELISTED
The AES Corporation
AESC
| $79.6M | 0.01% |
835,115
-691,572
| -45% | -$67.8M |
|
842
Enphase Energy
ENPH
$5.39B
| $79M | 0.01% |
432,087
-23,601
| -5% | -$4.92M |
|
843
LPL Financial
LPLA
$29.5B
| $77.7M | 0.01% |
485,145
-136,036
| -22% | -$22.5M |
|
844
Hershey
HSY
$37.4B
| $77.5M | 0.01% |
400,567
-45,752
| -10% | -$8.28M |
|
845
Power Integrations
POWI
$3.48B
| $76.9M | 0.01% |
828,241
-41,788
| -5% | -$4.1M |
|
846
Emcor
EME
$36.7B
| $76.9M | 0.01% |
603,816
-8,510
| -1% | -$1.05M |
|
847
Choice Hotels
CHH
$4.71B
| $76.9M | 0.01% |
492,808
-4,772
| -1% | -$685K |
|
|
ACBI
848
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $76.8M | 0.01% |
2,668,681
-131,004
| -5% | -$3.7M |
|
849
Cal-Maine
CALM
$3.87B
| $76.4M | 0.01% |
2,066,231
-97,607
| -5% | -$3.53M |
|
850
Huron Consulting
HURN
$2.47B
| $76.3M | 0.01% |
1,528,241
+58,828
| +4% | +$2.94M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.